Invesco Ltd. Axsome Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 625,179 shares of AXSM stock, worth $64.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

625,179

Previous 557,861 12.07%

Holding current value

$64.9 Million

Previous $44.9 Million 25.09%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$78.93 - $95.84 $5.31 Million - $6.45 Million	67,318 Added 12.07%	625,179 $56.2 Million
Q2 2024 Aug 13, 2024	BUY	$65.72 - $80.5 $20.5 Million - $25.1 Million	312,208 Added 127.09%	557,861 $44.9 Million
Q1 2024 May 14, 2024	BUY	$69.39 - $97.64 $13.8 Million - $19.5 Million	199,490 Added 432.14%	245,653 $19.6 Million
Q4 2023 Feb 12, 2024	SELL	$57.42 - $83.61 $934,682 - $1.36 Million	-16,278 Reduced 26.07%	46,163 $3.67 Million
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $7.56 Million - $8.97 Million	-109,131 Reduced 63.61%	62,441 $4.36 Million
Q2 2023 Aug 11, 2023	BUY	$58.41 - $90.35 $6.49 Million - $10 Million	111,045 Added 183.46%	171,572 $12.3 Million
Q1 2023 May 12, 2023	SELL	$58.39 - $75.0 $4.61 Million - $5.92 Million	-78,932 Reduced 56.6%	60,527 $3.73 Million
Q4 2022 Feb 13, 2023	SELL	$39.94 - $79.72 $1.26 Million - $2.52 Million	-31,591 Reduced 18.47%	139,459 $10.8 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $5.73 Million - $11.1 Million	158,821 Added 1298.72%	171,050 $7.63 Million
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $5,217 - $11,220	-240 Reduced 1.92%	12,229 $469,000
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $1,327 - $2,317	56 Added 0.45%	12,469 $516,000
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $36,594 - $51,685	-1,192 Reduced 8.76%	12,413 $469,000
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $3 Million - $10.3 Million	-150,778 Reduced 91.72%	13,605 $448,000
Q2 2021 Aug 17, 2021	BUY	$50.63 - $73.5 $1.63 Million - $2.37 Million	32,250 Added 24.41%	164,383 $11.1 Million
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $14.9 Million - $21.7 Million	-266,959 Reduced 66.89%	132,133 $7.48 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $1.88 Million - $2.46 Million	-28,396 Reduced 6.64%	399,092 $32.5 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $4.86 Million - $6.11 Million	-71,151 Reduced 14.27%	427,488 $30.5 Million
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $7.96 Million - $15.7 Million	-159,583 Reduced 24.24%	498,639 $41 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $1.93 Million - $4.75 Million	46,863 Added 7.67%	658,222 $38.7 Million
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $5.65 Million - $35.9 Million	-337,946 Reduced 35.6%	611,359 $63.2 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $2.87 Million - $4.13 Million	141,796 Added 17.56%	949,305 $19.2 Million
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $3.27 Million - $6.26 Million	-242,969 Reduced 23.13%	807,509 $20.8 Million
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $2.76 Million - $17.2 Million	1,050,478 New	1,050,478 $14.9 Million

Others Institutions Holding AXSM

# of Institutions

327

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account